Former Genentech researcher Lélia Delamarre appointed head of R&D at Medici Therapeutics; Intellia hires Scholar Rock CMO
Lélia Delamarre, a former senior scientist at Genentech, announced on LinkedIn that she will lead research and development at Medici Therapeutics, a cancer‑focused biotech backed by ARCH venture partners.
Intellia Therapeutics disclosed that it has recruited the chief medical officer from Scholar Rock, adding a seasoned executive to its leadership team as it expands its pipeline.
These moves highlight a broader pattern of experienced Genentech alumni taking senior roles at emerging biotech companies, potentially accelerating development efforts across the sector.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Ex-Genentech scientist joins Ira Mellman at Medici; Intellia poaches CMO from Scholar Rock”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that